Halozyme Therapeutics Inc $9.75

down -0.27


20/8/2014 04:00 PM  |  NASDAQ : HALO  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get HALO Trend Analysis - it has outperformed the S&P 500 by 19%

Partner Headlines

  1. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  2. Halozyme Therapeutics Receives Favorable FDA Decision

    Benzinga
  3. Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 ...

    Benzinga
  4. Benzinga's Top Initiations

    Benzinga
  5. JP Morgan Initiates Halozyme Therapeutics With Outperform

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. Mid-Day Market Update: US Stocks Surge; PVH Shares Slip On Downbeat Results

    Benzinga
  8. Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth ...

    Benzinga
  12. Mid-Day Movers: GORO, HALO, COCO, UEC, EVDY Moving Higher; RDEN, CALL, ...

    Benzinga
  13. Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises ...

    Benzinga
  14. Mid-Morning Market Update: Markets Gain; Elizabeth Arden To Explore Strategic ...

    Benzinga
  15. Morning Market Movers

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Benzinga's Top Initiations

    Benzinga
  21. Markets Falling? Get Your Defense Ready

    Benzinga
  22. Morning Market Losers

    Benzinga
  23. Benzinga's Top #PreMarket Losers

    Benzinga
  24. UPDATE: Halozyme Reports Clinical Hold of PEGPH20 Pancreatic Cancer Trial ...

    Benzinga
  25. Biotechs Struggling To Find A Bottom

    Benzinga
  26. Halozyme Announces Preclinical Data Presentations At The Association Of ...

    Benzinga
  27. Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum ...

    Benzinga
  28. Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat ...

    Benzinga
  29. Halozyme Shares Plummet as Concerns Halt Trial

    FoxBusiness
  30. Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates

    Benzinga
  31. Benzinga's Top #PreMarket Losers

    Benzinga
  32. UPDATE: Halozyme Announces Temporary Halt of Phase 2 Trial Enrollment

    Benzinga
  33. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 ...

    Benzinga
  34. Morning Market Movers

    Benzinga
  35. Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, ...

    Benzinga
  36. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  37. UPDATE: Halozyme Spikes Higher on Positive CNBC Comments

    Benzinga
  38. Microsoft's First Xbox TV Series Slated For 1H 2014

    Benzinga
  39. Hottest Game Systems For Christmas: PlayStation 4 vs. Xbox One vs. Wii ...

    Benzinga
  40. Halozyme Receives Milestone Payment of $10M from Roche Following Commercial ...

    Benzinga
  41. Coming Soon: Microsoft Cortana vs. Apple Siri (AAPL, MSFT)

    Benzinga
  42. Halozyme Announces Roche Receives Marketing Authorization for Herceptin ...

    Benzinga
  43. Benzinga Market Wrap for Thursday, August 1: Record Highs!

    Benzinga
  44. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  45. Mid-Afternoon Market Update: Trulia Rises as Hanger Drops on its Second-Quarter ...

    Benzinga
  46. Mid-Day Market Update: Yelp Surges On Narrower Loss, SunPower Shares Decline

    Benzinga
  47. ViroPharma Kills Halozyme Combo Trial; Stocks Fall

    IBD
  48. Mid-Morning Market Update: Markets Rally, Procter & Gamble Earnings Top ...

    Benzinga
  49. Halozyme Issued Update on ViroPharma Phase 2 Trial of C1 Esterase Inhibitor ...

    Benzinga
  50. Benzinga's Top Pre-Market Losers

    Benzinga
Trading Center